Presentation TCT 2025 The Cutting Edge of AI in Structural and Valvular Heart Disease: What’s Next? Presenter: Partho P. Sengupta October 26, 2025
Presentation TCT 2025 TCT 792: First-in-human experience with a novel self-expandable coronary sinus reducer for treating symptomatic epicardial and microvascular ischemic heart disease Presenter: Francesco Giannini October 26, 2025
Presentation TCT 2025 Management of Aortic Stenosis PLUS... Concomitant and Multivalvular Heart Disease Presenter: Gilbert H. L. Tang October 26, 2025
Presentation TCT 2025 Keynote Lecture: AI-Powered Screening of Heart Disease: Future Trends and Opportunities Presenter: Geoffrey Tison October 26, 2025
Presentation TCT 2025 Noise to Knowledge: Accelerating Detection of Valvular Heart Disease with Stethophone AI-Phonoscopy. Presenter: Mark Attila Opauszky October 26, 2025
Presentation TCT 2025 Earlier Detection of Valvular Heart Disease Presenter: Pierre Elias October 26, 2025
Presentation TCT 2025 12-Lead AI ECG Algorithm to Predict Coronary Flow Reserve and Capacity as Verified by PET-CT (Heartio) Presenter: Michael Leasure October 26, 2025
Presentation TCT 2025 Role of Mitral Balloon Valvuloplasty in Today's Treatment of Structural Heart Disease Presenter: Mariama Akodad October 26, 2025
Presentation TCT 2025 TCT 316: Duct Stenting versus Surgical Shunting in Patients with Congenital Duct-dependent Heart Disease. Presenter: Ananya Prasad October 26, 2025
Presentation TCT 2025 TCT 314: Post-Ligation Cardiac Syndrome Following Surgical vs. Transcatheter PDA Closure in Preterm Infants: A Systematic Review and Meta-Analysis Presenter: Candela Lang October 26, 2025
Presentation TCT 2025 TCT 315: Incidence of fenestrated atrial septal defects in patients referred for PFO closure Presenter: Vandan Upadhyaya October 26, 2025
Presentation TCT 2025 TCT 311: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A multi-center, randomized, parallel-controlled, non-inferiority clinical trial Presenter: Shasha Chen October 26, 2025
Presentation TCT 2025 TCT 312: Patent Foramen Ovale and Red Blood Cell Dysfunction: Quantifying Morphotype-Dependent Risk via Computational Fluid Dynamics Presenter: Daniela Trabattoni October 26, 2025
Presentation TCT 2025 TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR Presenter: Robert Kay October 26, 2025
Presentation TCT 2025 TCT 71: Detection of Light Chain Amyloidosis Cardiomyopathy (AL-CM) by Artificial Intelligence Analysis of ECG and Echocardiography Presenter: Joshua Finer October 26, 2025
Presentation TCT 2025 TCT 306: Oxygen Desaturation During Stress Tests to Identify Migraineurs with Functionally Significant Patent Foramen Ovale Presenter: Sammy Shaker October 26, 2025
Presentation TCT 2025 TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study Presenter: Shayan Khan October 26, 2025
Presentation TCT 2025 TCT 307: 20-Year Follow-up After Patent Foramen Ovale Closure in Patients With Cryptogenic Embolism Presenter: Pablo Vidal Calés October 26, 2025
Presentation TCT 2025 TCT 74: Survival Outcomes Following TAVR in Tafamidis-Treated Cardiac Amyloidosis: A Propensity-Matched Analysis Presenter: Tamari Lomaia October 26, 2025
Presentation TCT 2025 TCT 309: Temporal Trends in the Incidence and Mortality of Congenital Heart Disease in Europe Over 3 Decades Presenter: Ahmed A. Abdulelah October 26, 2025